Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Edgewise Therapeutics, Inc. | Chief Financial Officer | Common Stock | 35.2K | $666K | $18.91 | May 2, 2024 | Direct |
Edgewise Therapeutics, Inc. | Chief Financial Officer | Restricted Stock Units | 23.1K | $437K | $18.91 | Aug 12, 2024 | Direct |
Edgewise Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 139K | Aug 12, 2024 | Direct | ||
Elevation Oncology, Inc. | Director | Stock Option (Right to Buy) | 35K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EWTX | Edgewise Therapeutics, Inc. | Aug 12, 2024 | 2 | $0 | 4 | Aug 14, 2024 | Chief Financial Officer |
ELEV | Elevation Oncology, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
EWTX | Edgewise Therapeutics, Inc. | May 1, 2024 | 3 | -$40.8K | 4 | May 3, 2024 | Chief Financial Officer |
EWTX | Edgewise Therapeutics, Inc. | Jan 23, 2024 | 3 | -$1.25M | 4 | Jan 25, 2024 | Chief Financial Officer |
EWTX | Edgewise Therapeutics, Inc. | Aug 17, 2023 | 1 | $0 | 4 | Aug 18, 2023 | Chief Financial Officer |
EWTX | Edgewise Therapeutics, Inc. | Jun 22, 2023 | 2 | $7.1K | 4 | Jun 26, 2023 | Chief Financial Officer |
ELEV | Elevation Oncology, Inc. | Jun 16, 2023 | 1 | $0 | 4 | Jun 21, 2023 | Director |
EWTX | Edgewise Therapeutics, Inc. | May 1, 2023 | 3 | -$11.9K | 4 | May 3, 2023 | Chief Financial Officer |
EWTX | Edgewise Therapeutics, Inc. | Aug 8, 2022 | 1 | $0 | 4 | Aug 10, 2022 | Chief Financial Officer |
ELEV | Elevation Oncology, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
EWTX | Edgewise Therapeutics, Inc. | May 23, 2022 | 2 | $0 | 4 | May 25, 2022 | Chief Financial Officer |
EWTX | Edgewise Therapeutics, Inc. | May 1, 2022 | 1 | $0 | 4 | May 3, 2022 | Chief Financial Officer |
EWTX | Edgewise Therapeutics, Inc. | Aug 17, 2021 | 1 | $0 | 4 | Aug 19, 2021 | Chief Financial Officer |
ELEV | Elevation Oncology, Inc. | Jun 24, 2021 | 0 | $0 | 3 | Jun 24, 2021 | Director |